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Introduction
The endogenous circadian rhythms in mammals are driven by a network of clock genes. These 
clock genes in turn regulate behavioral and physiological changes that follow a rhythm of 
approximately 24 hours [1]. The functions of all of the different types of brain cells in this process 
are not completely known and characterized. It is known that the brain region, the suprachiasmatic 
nucleus (SCN) in the hypothalamus, is essential to maintain the body’s circadian rhythm. The role 
of the neuronal cells in this circadian rhythm has been studied extensively. However, recent studies 
have shown a circadian rhythmicity in glial cells, such as the astrocytes, as well [2]. Even without 
complete characterization of glial cells, there are reasons to consider astrocytes as crucial to 
circadian rhythm: they secrete gliotransmitters such as ATP in a circadian fashion, express 
circadian levels of glial fibrillary acidic protein (GFAP), and the disruption of glial metabolism has 
shown to alter circadian locomotor activity in some experiments [3].
In view of these recent findings, we propose to investigate the role of the principal glial cells 
(astrocytes) in the overall circadian rhythmicity in mice. Among the core network of clock genes, 
Bmal1 is a key gene which when ablated induces arrhythmicity at molecular and behavioral levels.
This study is intended to advance the current knowledge in the circadian rhythm field. It will add 
to the growing body of knowledge on the role of glial cells in circadian rhythm beyond the original 
idea that the central circadian pacemaker of mammals is solely driven by neurons. Understanding 
the role of the glial cells in circadian rhythmicity in mice, may help understand the same in humans. 
That in turn may provide insight into and help treat diseases that are correlated with chronic 
disruption of the circadian clock; such as diabetes, some cardiovascular diseases, and cancer [4].
BMAL1-cKO Mice Maintain Locomotor Circadian 
Rhythmicity
Figure 3. Circadian rhythmicity is 
not significantly different between 
WT and GFAP-BMAL1-cKO mice. 
From top to bottom A and B show 
running wheel data from WT and 
GFAP-BMAL1-cKO mice ages 
ranging from 8-26 weeks, 
respectively. Green represents 
active running wheel use. After a 
few days of 12:12 LD conditions 
acclimation, data was collected for 
2 weeks LD (top panel), 3 weeks 
DD (middle panel), and 2 weeks 
of skeleton lighting protocol 
(bottom panel). There was no 
significant difference between 
each group in terms of amplitude 
or period in any of the lighting 
regimens. Averages shown below.
KO n=6, WT n=5
Research Question
We hypothesize that the lack of Bmal1 in astrocytes will impact circadian rhythmicity, at the 
molecular level (gene expression via assessment of core clock gene Per2 expression), as well 
as in terms of whole animal behavior (running wheel activity on different lighting regimens). 
Future Directions
• Same experiment plan with new mouse line (B6.Cg-Tg(Gfap-cre)77.6Mvs/2J) which 
should have no Cre recombinase activity in postnatal or adult neural stem cells (or 
their progeny) as well as in astrocytes to better selectively target astrocytes.
• Investigate any evidence of astrogliosis in these mouse lines with the use of imaging 
of hippocampal regions and Western blots to quantify GFAP expression.
Summary and Conclusions
• In vitro control astrocyte cultures maintain a rhythmic expression of Per2, while 
knocking out BMAL1 causes arrhythmic expression of  Per2.
• Running wheel data indicates no difference in locomotor activity between control 
and knock out mice suggesting the gene in astrocytes is not essential to maintain 
circadian rhythmicity.
• PMT clock knockout of BMAL1 does not always lead to locomotor problems.
mPER2::LUC Astrocyte Culture
Figure 2. Rhythmicity of the mPER2::LUC astrocyte 
culture in vitro. Dramatically decreased rhythm seen 
in KO. (Marker for clock not functioning).
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Figure 1. Bmal1 in neurons and astrocytes in 
control and knock out mice. Green indicates Bmal1 
and red indicates the cell type. As shown, Bmal1 
was successfully knocked out of astrocytes 
(GFAP), but remained in other cell types (NeuN). 
Astrocyte Specific BMAL1 KO: An astrocyte specific BMAL1 KO mouse line was created through 
breeding Tg(GFAP-Cre) and Bmal1flx/flx mice. GFAP-Cre transgenic mice from founder line 73.12 
have Cre recombinase expression directed by the mouse glial fibrillary acidic protein promoter. Cre
expression is observed in astrocytes in the brain and spinal cord, as well as postnatal and adult 
GFAP-expressing neural stem cells and their progeny in the brain.
Immunohistochemistry and Imaging: 100 micron coronal brain sections were created from both
WT (control) and GFAP-BMAL1-cKO mouse brains and were examined by co-staining for BMAL1
and one of the following: glial fibrillary acidic protein (GFAP) or neuronal nuclei (NeuN). The primary
antibody, which included rabbit anti-Bmal1 (1:200) and one of the following: mouse anti-GFAP
(1:200) and mouse anti-NeuN (1:200), was applied for 3 days at 4C. The secondary antibody
containing Alexa Fluor 488 goat-anti-rabbit (1:200) and Alexa Fluor 594 goat-anti-mouse (1:200)
was applied overnight (4C). The success of the GFAP-BMAL1-cKO mouse was assayed via
confocal microscopy.
Actogram: The ability for the control and KO mice to maintain circadian rhythms was assayed by
first entraining to a 12 hours of light and 12 hours of dark (12:12 LD) daily schedule. After
approximately two weeks of 12:12 LD entrainment, the mice were placed in 24 hour darkness (DD)
for 3 weeks. Lastly, the mice were placed in a skeleton light protocol which consists of a 1 hour,
1000 lux light pulse every 12 hours. Each cage included a monitored running wheel, which recorded
every turn of the wheel, creating waking/sleeping pattern data which was then analyzed to show
any effects on circadian rhythmicity [5].
Bioluminescence: Photomultiplier tubes experiments were done with astrocyte cultures by placing
control and KO samples (GFAP-Cre and Bmal1flx/flx bred with Per2 to create a triple knockout) in a
Lumicycle to assess gene expression as shown below. The Lumicycle measures every time a
photon is released.
